Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine Academic Article uri icon

Overview

MeSH Major

  • Adenoviridae
  • Antimetabolites
  • Flucytosine
  • Genetic Therapy
  • Genetic Vectors
  • Liver Neoplasms
  • Prodrugs

publication date

  • May 20, 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9195221

Additional Document Info

start page

  • 985

end page

  • 1001

volume

  • 8

number

  • 8